Literature DB >> 34036650

Biological and methodological factors affecting V ̇ O 2 max response variability to endurance training and the influence of exercise intensity prescription.

Samuel Meyler1, Lindsay Bottoms1, Daniel Muniz-Pumares1.   

Abstract

NEW
FINDINGS: What is the topic of this review? Biological and methodological factors associated with the variable changes in cardiorespiratory fitness in response to endurance training. What advances does it highlight? Several biological and methodological factors exist that each contribute, to a given extent, to response variability. Notably, prescribing exercise intensity relative to physiological thresholds reportedly increases cardiorespiratory fitness response rates compared to when prescribed relative to maximum physiological values. As threshold-based approaches elicit more homogeneous acute physiological responses among individuals, when repeated over time, these uniform responses may manifest as more homogeneous chronic adaptations thereby reducing response variability. ABSTRACT: Changes in cardiorespiratory fitness (CRF) in response to endurance training (ET) exhibit large variations, possibly due to a multitude of biological and methodological factors. It is acknowledged that ∼20% of individuals may not achieve meaningful increases in CRF in response to ET. Genetics, the most potent biological contributor, has been shown to explain ∼50% of response variability, whilst age, sex and baseline CRF appear to explain a smaller proportion. Methodological factors represent the characteristics of the ET itself, including the type, volume and intensity of exercise, as well as the method used to prescribe and control exercise intensity. Notably, methodological factors are modifiable and, upon manipulation, alter response rates to ET, eliciting increases in CRF regardless of an individual's biological predisposition. Particularly, prescribing exercise intensity relative to a physiological threshold (e.g., ventilatory threshold) is shown to increase CRF response rates compared to when intensity is anchored relative to a maximum physiological value (e.g., maximum heart rate). It is, however, uncertain whether the increased response rates are primarily attributable to reduced response variability, greater mean changes in CRF or both. Future research is warranted to elucidate whether more homogeneous chronic adaptations manifest over time among individuals, as a result of exposure to more homogeneous exercise stimuli elicited by threshold-based practices.
© 2021 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.

Entities:  

Keywords:  cardiorespiratory fitness; endurance training; exercise prescription; response variability

Mesh:

Year:  2021        PMID: 34036650     DOI: 10.1113/EP089565

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  4 in total

1.  Physical activity phenotypes and mortality in older adults: a novel distributional data analysis of accelerometry in the NHANES.

Authors:  Marcos Matabuena; Paulo Félix; Ziad Akram Ali Hammouri; Jorge Mota; Borja Del Pozo Cruz
Journal:  Aging Clin Exp Res       Date:  2022-10-02       Impact factor: 4.481

2.  Is there an association between total physical activity level and VO2max among fitness club members? A cross-sectional study.

Authors:  Elene Mauseth Tangen; Christina Gjestvang; Trine Stensrud; Lene A H Haakstad
Journal:  BMC Sports Sci Med Rehabil       Date:  2022-06-17

Review 3.  Hierarchical framework to improve individualised exercise prescription in adults: a critical review.

Authors:  Elias Lehtonen; Dominique Gagnon; Daniela Eklund; Kaisa Kaseva; Juha Evert Peltonen
Journal:  BMJ Open Sport Exerc Med       Date:  2022-06-07

4.  Determination of exercise intensity domains during upright versus supine cycling: a methodological study.

Authors:  Damir Zubac; Vladimir Ivančev; Vincent Martin; Antonio Dello Iacono; Cécil J W Meulenberg; Adam C McDonnell
Journal:  PeerJ       Date:  2022-04-13       Impact factor: 3.061

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.